R.a. Session Ii.

Companies

• Taysha Gene Therapies, Inc.Board member Sep 23, 2020 to Dec 23, 2022¹
• Taysha Gene Therapies, Inc.Chief executive officer Sep 23, 2020 to Feb 25, 2022¹
• Taysha Gene Therapies, Inc.President Sep 23, 2020 to Feb 25, 2022¹
• Renovacor, Inc.Board member Apr 27, 2020 to Apr 27, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TGTaysha Gene Therapies, Inc. TSHA9,012,837 shares³$33.9M at $3.77Jul 14, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 13, 2023Sold 5,344 shares at $0.70 of Taysha Gene Therapies, Inc.³
• Jul 12, 2023Sold 80,528 shares at $0.71 of Taysha Gene Therapies, Inc.³
• Jun 23, 2023Sold 18,100 shares at $0.70 of Taysha Gene Therapies, Inc.⁴
• Jun 22, 2023Sold 10,508 shares at $0.70 of Taysha Gene Therapies, Inc.⁴
• Jun 21, 2023Sold 138,962 shares at $0.70 of Taysha Gene Therapies, Inc.⁵
• Jun 20, 2023Sold 295,653 shares at $0.71 of Taysha Gene Therapies, Inc.⁵
• Mar 6, 2023Other 251,296 shares of Taysha Gene Therapies, Inc.⁶
• Nov 23, 2021Bought 26,008 shares at $12.65 of Taysha Gene Therapies, Inc.⁷
• Nov 23, 2021Bought 16,510 shares at $12.12 of Taysha Gene Therapies, Inc.⁷